KR20020013670A - Probiotic preparations for aquacultured fish and its production method - Google Patents

Probiotic preparations for aquacultured fish and its production method Download PDF

Info

Publication number
KR20020013670A
KR20020013670A KR1020000047066A KR20000047066A KR20020013670A KR 20020013670 A KR20020013670 A KR 20020013670A KR 1020000047066 A KR1020000047066 A KR 1020000047066A KR 20000047066 A KR20000047066 A KR 20000047066A KR 20020013670 A KR20020013670 A KR 20020013670A
Authority
KR
South Korea
Prior art keywords
lactobacillus
microbial
lactobacillus plantarum
culture
fish
Prior art date
Application number
KR1020000047066A
Other languages
Korean (ko)
Other versions
KR100371503B1 (en
Inventor
백남수
Original Assignee
백남수, 권오훈
주식회사 메디오젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 백남수, 권오훈, 주식회사 메디오젠 filed Critical 백남수, 권오훈
Priority to KR10-2000-0047066A priority Critical patent/KR100371503B1/en
Publication of KR20020013670A publication Critical patent/KR20020013670A/en
Application granted granted Critical
Publication of KR100371503B1 publication Critical patent/KR100371503B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/24Lactobacillus brevis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/25Lactobacillus plantarum
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE: A microbial preparation useful as an additive to feeds for fish farming and a producing method thereof are provided, thereby improving the tolerance to diseases and decreasing lethality of fish. CONSTITUTION: The microbial preparation MGD100(KFCC-11189) useful as an additive to feeds for fish farming consists of Lactobacillus plantarum, Lactobacillus brevis and Enterococcus faecium in a ratio of 1:1:1. The microbial preparation MGD100(KFCC-11189) has antimicrobial activity to Staphylococcus aureus (ATCC6538), Vibrio cholerae (ATCC 14547), Escherichia coli (ATCC 29522), Salmonella enteritidis (IFO 3313), and Pseudomonas aeruginosa (IFO 3080), and is viable under conditions of the temperature of 15 to 25 deg.C and the salt concentration of 1 to 6%. The microbial preparation MGD100(KFCC-11189) is produced by mixing freeze-dried Lactobacillus plantarum, Lactobacillus brevis and Enterococcus faecium.

Description

양식어류의 사료첨가제용 미생물 제제 및 그 제조방법{Probiotic preparations for aquacultured fish and its production method}Probiotic preparations for aquacultured fish and its production method

[산업상 이용분야][Industrial use]

본 발명은 사료첨가제용 미생물 제제 및 그 제조방법에 관한 것으로서, 더욱 상세하게는 어류의 항병력 증진 및 발육과 소화를 촉진시키고 항생제 대신 미생물 제제를 사용함으로써 항생제 내성균의 발현을 방지시키는 사료첨가제용 미생물 제제 및 상기 미생물 제제에 사용되는 분리 미생물들을 고농도 대량배양 할 수 있도록 배양공정을 확립하고 또한 상기 미생물들의 배양여액 건조물을 사료첨가제로 이용할 수 있게 하는 상기 미생물 제제의 제조방법에 관한 것이다.The present invention relates to a microbial preparation for feed additives and a method of manufacturing the same, and more particularly, to promote the anti-histories and promote the development and digestion of fish and to prevent the expression of antibiotic resistant bacteria by using microbial agents instead of antibiotics. And it relates to a method for producing the microbial preparation to establish a culture process to enable high-density cultivation of the separated microorganisms used in the microbial preparation and to use the culture filtrate dried of the microorganisms as a feed additive.

[종래기술][Private Technology]

최근 사료첨가제에 항생제 사용 규제 강화에 의해 미생물 제제의 수요와 공급이 증가하고 있다. 그러나 양식어의 사료에 사용되는 미생물 제제는 사람이나 가축에 사용되는 최적발육온도 37℃의 미생물을 이용함으로서 15℃∼25℃에서 생육하는 양식어에는 부적절하며 특히 해수 양식어의 경우 높은 염농도에도 견딜 수 없는 실정이다.Recently, demand and supply of microbial preparations are increasing due to tightening regulations on the use of antibiotics in feed additives. However, the microbial preparations used in feed for fish farms are not suitable for farmed fish growing at 15 ℃ to 25 ℃ by using microorganisms with optimal development temperature of 37 ℃ for human or livestock, and especially in seawater farmed fish. It is impossible.

저온·고염에서 생육 가능한 미생물 제제의 개발은 어류의 항병력 증진과 발육 및 소화를 촉진시켜 어가 소득수준 향상에 기여할 수 있고, 항생제 남용을 막을 수 있어 항생제 수입대체에 따른 외화낭비를 막을 수 있다는 점에서 그 중요성이 매우 크다. 또한, 배양여액을 배출하지 않고 건조분말로 제제화하여 사료첨가제로 이용함으로써 폐수 정화를 위한 비용이 절감되며 경제적인 생산 및 제조방법이 구축될 것이다.The development of microbial products that can be grown at low temperature and high salt can contribute to the improvement of fish income level by promoting the anti-medical history, development and digestion of fish, and it can prevent the abuse of antibiotics due to the substitution of antibiotics. Its importance is very important. In addition, by formulating a dry powder without discharging the filtrate and using it as a feed additive, the cost for waste water purification will be reduced and an economical production and manufacturing method will be established.

본 발명의 목적은 양식어류에 대해 항생물질의 남용을 억제 및 대체 할 수 있는 미생물 제제 개발의 일환으로서 어류의 장내에 유익세균총을 형성하게 하고 성장촉진은 물론 면역력 증강과 질병의 예방 및 수질오염 억제 등의 기능을 수행하는 미생물 제제를 제공하기 위한 것이다.An object of the present invention is to develop a beneficial microflora in the intestines of fish as part of the development of microbial preparations that can suppress and replace antibiotics in aquaculture, promote growth, as well as increase immunity and disease prevention and water pollution. It is to provide a microbial agent for performing such functions.

도 1은 본 발명에 따른 제제화 방법의 흐름도1 is a flow chart of a formulation method according to the invention

상기와 같은 본 발명의 목적을 달성하기 위하여 본 발명은 기탁번호 제 KFCC-11189호로 기탁되어 있고, 어류의 사료첨가제로 사용되는 락토바실러스 플란타럼(Lactobacillus plantarum), 락토바실러스 브레비스(Lactobacillus brevis), 엔테로코커스 훼시움(Enterococcus faecium)과 그 배양여액 건조물을 함유한 미생물 제제 MDG100을 제공한다.In order to achieve the object of the present invention as described above, the present invention has been deposited as deposit No. KFCC-11189, used as a feed additive of fish Lactobacillus plantarum (Lactobacillus plantarum), Lactobacillus brevis (Lactobacillus brevis), Provided is a microbial preparation MDG100 containing Enterococcus faecium and dried culture filtrate.

본 발명은 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스훼시움 을 유산균 배양용 배지에서 종균배양하고, 상기 종균배양된 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움을 발효조에 접종하여 본 배양함으로써 상기 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움을 생산하는 단계; 본 배양된 미생물 배양액을 각각 원심분리하여 미생물 농축액을 수득하고, 탈지유(skim milk) 10% 및 말토스(maltose) 1%를 첨가하여 동결건조하는 단계; 동결건조된 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움과 배양여액의 건조물을 혼합하는 단계;를 포함하는 상기 미생물 제제의 제조방법을 제공한다.The present invention is seeded culture of Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fascium in the culture medium for lactobacillus, and the seed cultured Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fascium are inoculated in the fermenter. Producing the Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fascium by main culture; Centrifuging each of the cultured microbial cultures to obtain a microbial concentrate, and lyophilizing by adding 10% skim milk and 1% maltose; It provides a method for producing the microbial preparation comprising the step of mixing the lyophilized Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fasium and the dried product of the culture filtrate.

이하 본 발명을 더욱 상세히 설명하면 하기와 같다.Hereinafter, the present invention will be described in more detail.

어류의 생육환경 특성을 고려하여 저온 숙성 김치에서 분리한 미생물을 이용한 사료첨가제용 미생물 제제를 개발하였다. 사료첨가제용 균주로서는 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움이 분리·선정되었다. 미생물 제제에 이용될 분리 미생물들을 고농도 대량배양하고 배양여액을 이용할 수 있는 배양공정을 확립하였다.Considering the growth environment of fish, we developed a microbial preparation for feed additive using microorganisms isolated from low-temperature ripening kimchi. As strains for feed additives, Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fascium were isolated and selected. A culture process was established in which a large amount of isolated microorganisms to be used in the microbial preparations were cultured in high concentrations and the culture filtrate was used.

저온 숙성 김치를 분리원으로 하여 브레모크레졸 퍼플을 함유한 세균수 측정용 고체 배지(plate count agar)에서 노란색 환을 형성하는 200여 개의 단일 군집(colony)를 1차 분리하였으며 1차 분리된 균주를 NaCl이 6.0% 함유된 MRS 배지를 사용하여 15℃에서 3일간 배양하여 생육한 균주를 2차 선별하였다. 2차 선별된 균주를 25℃, 48시간 동안 MRS 액체배지에서 배양 후 상등액을 사용하여 에스케리치아 콜라이(Escherichia coli)에 대한 생육저해 활성을 비교하여 최종적으로 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움의 3종의 균주를 최종 선별하였다.As a source of low-temperature ripening kimchi as a separation source, 200 single colonies (yellow) forming a yellow ring were first isolated from a solid plate count agar containing Bremocresol Purple. The strain was grown for 2 days at 15 ℃ using MRS medium containing 6.0% NaCl was selected for the second time. The secondary screened strains were cultured in MRS liquid medium for 25 hours at 48 ° C., and then compared to growth inhibitory activity against Escherichia coli using supernatant. Finally, Lactobacillus plantarum, Lactobacillus brevis and Three strains of Enterococcus fascium were finally selected.

미생물 제제용으로 선정된 각 균주의 배양조건, 생리적특성을 바탕으로 미생물을 대량배양하기 위한 배양공정기술을 확립하기 위한 실험을 수행하였다.Based on the culture conditions and physiological characteristics of each strain selected for the preparation of microorganisms, experiments were conducted to establish a culture process technology for cultivating microorganisms in large quantities.

분리된 균주의 분류적, 생리적 특성을 감안하여 선택한 배지의 조성과 배양조건은 하기 표 1과 같다.The composition and culture conditions of the selected medium in consideration of the classification and physiological characteristics of the isolated strain are shown in Table 1 below.

표1Table 1

미생물 제제로 선정된 미생물(이하 기탁균주)의 항병력을 알기 위해 항균활성 조사를 원형여지를 사용하는 한천 분산법(agar diffusion)에 따라 실시하였다. 배양액의 항균활성에 대한 지시균은스타필로코코스 아우리우스(Staphylococcusaureus)ATCC6538,비브리오 콜레라(Vibrio cholerae)ATCC14547,에스케리치아 콜라이(Escherichia coli)ATCC29522,살모넬라 엔테리티디스(Salmonella enteritidis)IFO3313,슈도모나스 애류지노사(Pseudomonas aeruginosa)IFO3080를 사용하였다. 트립톤과 대두분을 함유한 고체배지(Tryptic soy agar) 10ml를 배양접시에 분주하여 고화시킨 후 그 위에 절당부이온배지(LB배지)에서 25-30℃로 24시간 배양한 지시균액을 105-106/ml의 균수가 되도록 첨가한 고체영양배지(agar 0.4% 함유) 2ml를 중층하고 다시 그 위에 기탁균주의 배양액 및 상등액 조제시료를 농도별로 묻힌 원형여지를 (직경 8mm)를 올려놓고 25℃에서 24시간 배양했을 때 지시균의 생육저지대의 폭을 측정하였으며 대조 항생물질로는 0.1% 아목시실린(amoxycillin)을 사용하여 비교하였다. 락토바실러스 브레비스의 항균활성을 측정한 결과는 대조약물과 비교할 때스타피로코코스 아우리우스(S.aureus)의 경우 배양액, 배양상등액, 상등액 중화시료 모두 대조약물 50㎕ 점적량 효과 이상의 항균활성을 보였다.비프리오 콜레라의 경우 배양액시료는 대조약물 30㎕의 점적량과 동등한 효과를 보였고에스케리치아 콜라이(E.coli)의 경우 전반적으로 대조약물이 우수하게 나타났다.살모넬라 엔테리티디스(S.enteritidis)의 경우 배양액시료 50㎕ 효과는 대조약물 10㎕의 점적량과 동등하였으며슈도모나스 애루지노사(P.aeruginosa)의 경우 배양시료 50㎕와 동등한 항균활성을 보였다.In order to know the history of the microorganisms selected as microbial agents (hereinafter, deposited strains), antimicrobial activity was investigated by agar diffusion using a circular filter. Instructions bacteria on antibacterial activity of the culture is Staphylococcus Cocos brother Julius (Staphylococcusaureus) ATCC6538, Vibrio cholera (Vibrio cholerae) ATCC14547, Escherichia coli (Escherichia coli) ATCC29522, Salmonella Entebbe utility disk (Salmonella enteritidis) IFO3313, Pseudomonas Ke Ryuji Pseudomonas aeruginosa IFO3080 was used. After solidification by dividing the tryptone and soy flour a solid medium (Tryptic soy agar) containing 10ml of the culture plate to the section assignment ion medium 24 hours the culture broth as indicated at 25-30 ℃ (LB medium) thereon; 5 Layer 2 ml of solid nutrient medium (containing agar 0.4%) added to -10 6 / ml of bacteria, and then put a circular filter (diameter 8mm) on which the culture solution and supernatant preparation of the deposited strain were buried. The incubation width of the indicator was measured when incubated for 24 hours at ℃ and compared with 0.1% amoxicillin as a control antibiotic. The results of measuring the antimicrobial activity of Lactobacillus brevis showed that the antimicrobial activity of Staphylococcus aureus (S.aureus) in the culture, culture supernatant, and supernatant neutralizing samples was greater than the 50 μl drop effect of the control drug. In the case of biprio cholera , the culture sample showed the same effect as the drop amount of 30 μl of the reference drug, and the control drug was excellent in the overall Escherichia coli (E.coli) . In the case of Salmonella enteritidis, 50 μl of the culture sample was equivalent to that of 10 μl of the control drug, and P. aeruginosa showed the same antimicrobial activity as 50 μl of the culture sample.

엔테로코커스 훼시움의 항균활성을 측정한 결과 대조약물과 비교할 때스타피로코코스 아우리우스의 경우 배양액과 배양상등액 및 상등액 중화시료등 모두 대조약물 10㎕ 점적량이 나타내는 항균효과 이상의 항균활성을 보였으며비브리오 콜레라의 경우 3종의 시료 모두 대조약물 30㎕점적량 효과와 비슷하였다.살모넬라 엔테리티디스의 경우도 3종의 시료 모두 대조약물 10㎕ 점적량의 효과와 비슷하였으며슈도모나스 애루지노사의 경우 배양액 시료 50㎕는 대조약물 50㎕의 효과와 동등하였다.Enterococcus hwesi antimicrobial results compared to the control drug of measuring the activity of the Titanium For star fatigue Cocos brother Julius showed a culture solution and culture supernatant and the supernatant was neutralized sample including both the control drug 10㎕ antimicrobial activity than one antimicrobial activity represents the amount of drip V. cholera In case of all three samples, the effect of 30µl drop of the reference drug was similar. In the case of Salmonella enteritidis, all three samples were similar to the effect of 10 μl drop of the reference drug. For Pseudomonas aeruginosa, 50 μl of the culture sample was equivalent to the effect of 50 μl of the control drug.

락토바실러스 플란타럼의 항균활성을 측정한 결과 대조약물과 비교할 때스타피로코코스 아우리우스의 경우 배양액시료는 대조약물 30㎕ 점적량과 같았으며 상등액의 경우 대조약물 10㎕ 점적량과 동일한 결과를 나타냈다.비브리오 콜레라의 경우 배양액 시료는 대조약물 30㎕의 점적량과 같았다.에스케리치아 콜라이의 경우 전반적으로 대조약물이 우수하게 나타났다.살모넬라 엔테리티디스의 경우 배양액시료 효과는 대조약물 30㎕의 점적효과와 비슷하였으며슈도모나스 애루지노사의 경우 배양액 및 상등액 시료가 대조약물 50㎕ 점적량의 효과보다 동등이상의 효과를 나타냈다.As a result of measuring the antimicrobial activity of Lactobacillus plantarum, in the case of Staphylococcus aurius , the culture sample was equivalent to the 30 μl drop of the reference drug and the supernatant showed the same result as the 10 μl drop of the control drug. . In the case of Vibrio cholera , the culture sample was equivalent to the drop amount of 30 µl of the reference drug. In the case of Escherichia coli , the control drug was excellent overall. In the case of Salmonella enteritidis, the effect of the culture sample was similar to that of the control drug 30 μl. In the case of Pseudomonas aeruginosa, the culture and supernatant samples showed an equivalent effect to the effect of the 50 μl drop of the control drug.

기탁균주는 MRS배지에서비브리오 콜레라균은 NaCl이 2.5%함유된 절당부이온배지(LB배지)에서 24시간 배양 후 시험군은 NaCl이 2.5%함유된 MRS배지에 기탁균주와비브리오 콜레라균이 각각 106/ml의 균수가 되도록 혼합 접종하였으며 대조군은 NaCl이 2.5% 함유된 절당부이온배지(LB배지)에 비브리오 콜레라균만 접종하였다. 접종된 각각의 배지는 25℃에서 정치 배양하면서 6시간 간격으로 배양액을 채취하여 멸균 생리식염수로 희석한 후 NaCl이 2.5% 함유된 락토스 액체(LB) 평판배지와 브로모크레졸 퍼플 배지에 도말하여 25℃에서 48시간 배양하였다. 배양 후 락토스 액체 평판배지에 나타난 군집으로부터비브리오 콜레라균수를 측정하였으며 브로모크레졸퍼플(BCP) 배지로부터 기탁균주의 생균수를 측정하였다.Deposited strains were cultured in MRS medium for Vibrio cholera bacteria for 24 hours in 2.5g NaCl-containing saengdangbuion medium (LB medium), and then the test group was placed in MRS medium containing 2.5% NaCl and 10 strains of Vibrio cholera bacteria. 6 / ml of the bacteria were inoculated and mixed, and the control group was inoculated with only Vibrio cholera bacteria in the lyse-coated ions medium (LB medium) containing 2.5% NaCl. Each inoculated medium was cultured at 25 ° C., and cultured at 6 hour intervals and diluted with sterile saline solution. Incubated for 48 hours at ℃. After incubation, the number of Vibrio cholera bacteria was measured from the colonies shown on the lactose liquid plate medium, and the viable cell counts of the deposited strains were measured from bromocresol purple (BCP) medium.

락토바실러스 브레비스 균주의비브리오 콜레라균에 대한 성장 저해능 및 살균력을 측정한 결과비브리오 콜레라단독배양의 경우에는 정상적인 성장을 하였으나 락토바실러스 브레비스와 혼합 배양의 경우 접종 후 8∼12시간 이후부터 균수가 감소하기 시작하여 30시간 이후 1×102/ml의 균수로 급감하였다. 그러나 락토바실러스 브레비스 균주는 9×108/ml의 생균수를 보였다.The growth inhibition and bactericidal activity of the Vibrio cholera strains of Lactobacillus brevis strains were normal, but the growth of the vibrio cholera alone was normal. After 30 hours, the number was drastically reduced to 1 × 10 2 / ml. However, Lactobacillus brevis strain showed a viable cell number of 9 × 10 8 / ml.

엔테로코커스 훼시움 균주의비브리오 콜레라균에 대한 성장 저해능 및 살균력을 측정한 결과비브리오 콜레라단독배양의 경우에는 정상적인 성장을 하였으나 엔테로코커스 훼시움과 혼합배양의 경우 접종 후 12시간까지는 정상적으로 진행되다 12시간 이후에는 급격히 감소하여 48시간에는 80/ml의 생균수를 나타냈으나 엔테로코커스 훼시움 균은 9.5×108/ml의 생균수를 유지하였다.The growth inhibition and bactericidal activity of the Vitroo cholera strains of Enterococcus fascium strains were normal, but the Vibrio cholera cultures showed normal growth. At 48 hours, the viable cell number was decreased to 80 / ml, but Enterococcus fascium maintained the viable cell count of 9.5 × 10 8 / ml.

락토바실러스 플란타럼 균주의비브리오 콜레라균에 대한 성장 저해능 및 살균력을 측정한 결과비브리오 콜레라단독배양의 경우에는 정상적인 성장을 하였으나 락토바실러스 플란타럼과 혼합배양의 경우 접종 후 18시간까지는 정상적으로 성장이 진행되다가 18시간 이후 균수가 급속히 감소하기 시작하여 48시간 이후부터는비브리오 콜레라균이 전혀 나타나지 않았으나, 락토바실러스 플란타럼 균은 6.3×108/ml의 생균수를 유지하였다.Growth inhibition and bactericidal activity of the Vibrio cholera bacteria of Lactobacillus plantarum strains were normal, but growth was normal in the Vibrio cholera alone culture but up to 18 hours after inoculation with Lactobacillus plantarum. After 18 hours, the number of bacteria began to decrease rapidly, and after 48 hours, no Vibrio cholera bacteria appeared, but the Lactobacillus plantarum bacteria maintained a viable cell count of 6.3 × 10 8 / ml.

기탁균주의 저온·고염의 환경에서 생육가능여부를 일반가축용 생균제로 사용중인 균종과 비교하여 상기 미생물 제제로 선정된 미생물들과 락토바실러스 애시도필러스(Lactobacillus acidophilus)는 MRS배지로, 락토바실러스 스포로제네스(Lactobacillus sporogenes)는 브로모크레졸 퍼플(BCP) agar, 락토바실스 비피더스(Lactobacillus bifidus)는 BL agar, 클로스트리디움 뷰티리콤(Clostridium butyricum)은 플루이드 치오글리콜레이트 배지(Fluid Thioglycolate Medium), 바실러스 서브틸리스(Bacillus subtilis)는 전분 배지에서 생육유무를 관찰하였다. 그 결과는 하기 표 2와 같다.The microorganisms and Lactobacillus acidophilus selected as the microbial preparations were MRS medium, Lactobacillus, in comparison with the type of microorganism used as a livestock probiotics in the environment of low temperature and high salt of deposited bacteria. Lactobacillus sporogenes is bromocresol purple (BCP) agar, Lactobacillus bifidus is BL agar, Clostridium butyricum is fluid thioglycolate medium, Bacillus subtilis observed growth in starch medium. The results are shown in Table 2 below.

기탁균주를 6ℓ발효조(NBS)에서 최적생산배지를 사용하여 배양한 후 원심분리하여 균체를 회수하였다. 회수된 균체는 탈지유(skim milk)10%와 말토스1%로 이루어진 동결건조 보호제와 혼합하여 균질화 한 후 -40℃로 동결시킨 다음 동결건조기(IL Shin Lab)에서 건조하였다. 건조된 균체는 분쇄하여 분말화 시킨 다음 멸균 생리식염수에 단계 희석하여 브로모크레졸 퍼플배지에 도말한 후 25℃에서 48시간 배양한 다음 생균수를 측정하여 동결건조 후의 생존율을 측정한 결과 동결전의 생균수를 100%로 간주하였을 때 동결건조 후의 생존율이 60%이상으로 측정되었다.The deposited strains were incubated in a 6 L fermentation tank (NBS) using an optimal production medium and then centrifuged to recover the cells. The recovered cells were homogenized by mixing with a lyophilized protective agent consisting of skim milk (10% skim milk) and maltose (1%), and then frozen at -40 ° C and dried in a lyophilizer (IL Shin Lab). The dried cells were pulverized, powdered, diluted in sterile physiological saline, plated in bromocresol purple medium, incubated at 25 ° C. for 48 hours, and viable cells were measured for viability before freeze-drying. Considering the number 100%, the survival rate after lyophilization was determined to be 60% or more.

인공위액은 고바야시(Kobayashi) 등의 방법에 따라 HCl을 사용하여 pH2.5로 조정한 MRS 액체배지에 펩신 1%를 첨가하여 사용하였다. 동결건조 균체분말 0.1g을 인공위액 10ml에 넣고 25℃에서 1시간 방치하였다. 인공위액에서 처리된 균체분말을 멸균 생리식염수에 단계 희석하여 브로모크레졸 퍼플배지에 도말한 다음 25℃에서 48시간 배양 후 생성된 군집(colony)수를 계측하여 인공위액 처리전의 생균수와 비교한 결과 인공위액 처리전의 생존율을 100%로 간주하였을 때 60%이상의 생존율을 보였다.Artificial gastric juice was used by adding 1% pepsin to the MRS liquid medium adjusted to pH2.5 using HCl according to the method of Kobayashi et al. 0.1g of lyophilized cell powder was placed in 10ml of artificial gastric juice and left at 25 ° C for 1 hour. The cell powder treated in artificial gastric juice was diluted in sterile physiological saline solution and plated in bromocresol purple medium, and the number of colonies generated after incubation at 25 ° C for 48 hours was measured and compared with the number of viable cells before gastric juice treatment. The survival rate was over 60% when the survival rate was 100%.

본 발명에 따른 제제화 방법을 도 1에 나타내었다.The formulation method according to the invention is shown in FIG. 1.

[실시예]EXAMPLE

본 발명의 바람직한 실시예 및 비교예를 기재한다. 그러나 하기한 실시예는 본 발명의 구성 및 효과를 나타내는 본 발명의 일 실시예일 뿐 본 발명이 하기한 실시예에 한정되는 것은 아니다.Preferred examples and comparative examples of the present invention are described. However, the following examples are merely examples of the present invention showing the constitution and effects of the present invention, and the present invention is not limited to the following examples.

본 발명에 따른 미생물 제제를 넙치에 투여하는 실험을 수행하였고 어체의증체율 및 치사율을 조사하였다. 양식 실험은 해수 양식장에서 넙치를 대상으로 실시하였다. 넙치 316마리를 수온 15℃∼25℃에서 50일간 사육하였다.Experiments were performed to administer the microbial preparations according to the present invention to the flounder, and the growth rate and mortality rate of the fish were investigated. Aquaculture experiments were conducted on flounder at the seawater farm. 316 flounder were bred for 50 days at water temperature of 15 ° C-25 ° C.

본 실시예에서는 미생물 제제를 사료 1kg당 1g씩 섞어 매일 공급하였다.In this example, the microbial preparation was mixed daily with 1 g of feed per kg.

상기 실시예에서 상기 미생물 제제를 공급하지 않는 것을 제외하고는 실질적으로 동일하게 실시하였다.The same practice was followed except that the microbial agent was not fed in this example.

상기 실시예 및 비교예에서 시일경과에 따른 넙치의 체중 증가를 조사하여 그 결과를 표 3에 나타내었다.In the Examples and Comparative Examples, the weight gain of the flounder according to the passage of time was examined, and the results are shown in Table 3.

상기 표에서와 같이 50일 동안 비교예에서는 평균 17.9%의 체중 증가가 관찰된 반면 실시예에서는 27.0% 증가를 보여 실시예에서 증체율이 50% 증가한 것으로 관찰되었다. 즉, 비교예의 어체의 체중 증가량보다 실시예의 어체의 체중 증가량이 1.5배에 달한다. 이는 투여한 미생물 및 배양건조물이 장의 기능을 강화시켜 소화율 등을 증가시키기 때문으로 사료된다.As shown in the table, an average weight gain of 17.9% was observed in the comparative example for 50 days, while in the example, a 27.0% increase was observed, and an increase of 50% was observed in the example. That is, the weight gain of the fish of the embodiment reaches 1.5 times higher than the weight gain of the fish of the comparative example. This is because the administered microorganisms and cultured dry foods enhance intestinal function and increase digestibility.

상기 실시예 및 비교예에서 시일 경과에 따른 넙치의 치사율을 조사하여 그 결과를 하기 표 4에 나타내었다.In the Examples and Comparative Examples, the mortality of flounder over time was examined and the results are shown in Table 4 below.

상기 표에서 보는 바와 같이 비교예에서 5%의 치사율을 보인 반면 실시예에서는 0%의 치사율을 보여 실시예에서 생존율이 우수한 것으로 관찰되었다. 이는 투여한 미생물이 어류의 병을 일으키는 균에 대한 항균성이 뛰어나고 항병력이 증진되어 어류가 병을 일으키지 않았기 때문으로 사료된다.As shown in the above table, the mortality rate of 5% was shown in the comparative example while the mortality rate of 0% was shown in the example, and the survival rate was excellent in the example. This may be because the microorganisms administered were excellent in antimicrobial activity against the bacteria causing fish disease and the anti-history was enhanced and the fish did not cause disease.

본 발명의 미생물 제제는 어류의 항병력을 증진시키고 소화효율의 개선에 의한 발육촉진 및 항생제 대체용으로 경제성이 있다.The microbial preparation of the present invention is economical for promoting growth and replacement of antibiotics by enhancing the anti-pathology of fish and improving digestion efficiency.

Claims (4)

기탁번호 제 KFCC-11189호로 기탁되어 있고, 어류의 사료첨가제로 사용되는 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움이 1:1:1의 혼합으로 이루어진 미생물 제제 MGD100.Microbial agent MGD100, deposited under No. KFCC-11189, consisting of a 1: 1: 1 mixture of Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fascium, used as feed additives for fish. 스타필로코코스 아우리우스(Staphylococcus aureus)ATCC6538,비비리오 콜레라(Vibrio cholerae)ATCC14547,에스케리치아 콜라이(Escherichia coli)ATCC29522,살모넬라 엔테리티디스(Salmonella enteritidis)IFO3313,슈도모나스 애루지노사(Pseudomonas aeruginosa)IFO3080에 대해 항균활성을 갖는 미생물 제제 MDG100 및 배양액 건조물. Staphylococcus aureus ATCC6538, Vibirio cholerae ATCC14547, Escherichia coli ATCC29522, Salmonella enteritidis IFO3313, Pseudomonas aeroinosa auginosa 30 Microbial agent MDG100 and culture medium dried having antimicrobial activity against. 온도 15℃∼25℃, 염분농도 1∼6%의 환경조건에서 생육할 수 있는 미생물 제제 MDG100Microbial preparation MDG100 capable of growing under environmental conditions of 15 ℃ -25 ℃ and 1-6% salinity. 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움 을 유산균 배양용 배지에서 종균배양하고, 상기 종균배양된 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움을 발효조에 접종하여 본 배양함으로써 상기 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움을 생산하는 단계; 본 배양된 미생물 배양액을 각각 원심분리하여 미생물 농축액을수득하고, 탈지유(skim milk) 10% 및 말토스 1%를 첨가하여 동결건조하는 단계; 동결건조된 락토바실러스 플란타럼, 락토바실러스 브레비스 및 엔테로코커스 훼시움과 배양여액 건조물을 혼합하는 단계;를 포함하는 상기 미생물 제제의 제조방법.Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fascium were cultured in a culture medium for lactobacillus culture, and the seed cultured Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fascium were inoculated into a fermenter and incubated. Producing the Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fascium; Centrifuging each of the cultured microbial cultures to obtain a microbial concentrate, and lyophilizing by adding 10% skim milk and 1% maltose; Mixing the lyophilized Lactobacillus plantarum, Lactobacillus brevis and Enterococcus fascium with the culture filtrate dried;
KR10-2000-0047066A 2000-08-14 2000-08-14 Probiotic preparations for aquacultured fish and its production method KR100371503B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2000-0047066A KR100371503B1 (en) 2000-08-14 2000-08-14 Probiotic preparations for aquacultured fish and its production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0047066A KR100371503B1 (en) 2000-08-14 2000-08-14 Probiotic preparations for aquacultured fish and its production method

Publications (2)

Publication Number Publication Date
KR20020013670A true KR20020013670A (en) 2002-02-21
KR100371503B1 KR100371503B1 (en) 2003-02-06

Family

ID=19683199

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-0047066A KR100371503B1 (en) 2000-08-14 2000-08-14 Probiotic preparations for aquacultured fish and its production method

Country Status (1)

Country Link
KR (1) KR100371503B1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100350093B1 (en) * 2002-03-29 2002-08-24 Jewoo Corp Feed additive for increase of the physiological activity of bred fish and promotion of the growth thereof using effective microorganisms and medicinal herbs, and manufacturing method thereof
KR100865075B1 (en) * 2007-03-27 2008-10-24 한국생명공학연구원 Novel probiotic strain Lactobacillus sp. SM1 showes high cell adherence
KR101658655B1 (en) * 2015-06-30 2016-09-23 (주)크린바이오 Novel STRAIN of Lactobacillus plantarum Isolated from Anguilla japonica and Probiotics for Fish Using Thereof
KR20210052718A (en) * 2019-10-30 2021-05-11 재단법인 환동해산업연구원 Feed additive comprising fermented mealworm and feed composition using the same
CN113749179A (en) * 2021-09-10 2021-12-07 南京工业大学 Application of curdlan in preparation of feed additive
KR20220083933A (en) * 2020-12-11 2022-06-21 재단법인 환동해산업연구원 Feed additive comprising lactic acid bacterium fermented Hermetia illucens and feed composition using the same
CN114806976A (en) * 2022-06-20 2022-07-29 中国科学院天津工业生物技术研究所 Lactobacillus brevis and preparation method of antibacterial substance thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101164876B1 (en) * 2010-03-10 2012-07-19 주식회사 메디오젠 Broccoli production fermented by lactic acid bacteria, which is anti-inflammatory and anti-Helicobacter pylori and method for preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2727517B2 (en) * 1992-07-24 1998-03-11 株式会社島津製作所 Feed for seafood
JP2730685B2 (en) * 1992-07-24 1998-03-25 株式会社島津製作所 How to cultivate seafood
JP2694861B2 (en) * 1992-09-30 1997-12-24 株式会社島津製作所 Biological feed for seafood
JPH08298982A (en) * 1995-05-02 1996-11-19 Aasu Giken:Kk Complex microbial pharmaceutical preparation
US5747020A (en) * 1995-05-15 1998-05-05 Pioneer Hi-Bred International, Inc. Bacterial treatment for silage
US5985336A (en) * 1995-06-07 1999-11-16 Novus International, Inc. Nutrient formulation and process for feeding young poultry and other animals

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100350093B1 (en) * 2002-03-29 2002-08-24 Jewoo Corp Feed additive for increase of the physiological activity of bred fish and promotion of the growth thereof using effective microorganisms and medicinal herbs, and manufacturing method thereof
KR100865075B1 (en) * 2007-03-27 2008-10-24 한국생명공학연구원 Novel probiotic strain Lactobacillus sp. SM1 showes high cell adherence
KR101658655B1 (en) * 2015-06-30 2016-09-23 (주)크린바이오 Novel STRAIN of Lactobacillus plantarum Isolated from Anguilla japonica and Probiotics for Fish Using Thereof
KR20210052718A (en) * 2019-10-30 2021-05-11 재단법인 환동해산업연구원 Feed additive comprising fermented mealworm and feed composition using the same
KR20220083933A (en) * 2020-12-11 2022-06-21 재단법인 환동해산업연구원 Feed additive comprising lactic acid bacterium fermented Hermetia illucens and feed composition using the same
CN113749179A (en) * 2021-09-10 2021-12-07 南京工业大学 Application of curdlan in preparation of feed additive
CN114806976A (en) * 2022-06-20 2022-07-29 中国科学院天津工业生物技术研究所 Lactobacillus brevis and preparation method of antibacterial substance thereof
CN114806976B (en) * 2022-06-20 2023-10-03 中国科学院天津工业生物技术研究所 Lactobacillus brevis and preparation method of antibacterial substances thereof

Also Published As

Publication number Publication date
KR100371503B1 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
RU2281326C2 (en) BACTERIUM STRAIN Escherichia coli USEFUL IN NORMALIZATION OF GASTROINTESTINAL TRACT PHYSIOLOGICAL ACTIVITY, PROBIOTIC COMPOSITION FOR NORMALIZATION OF GASTROINTESTINAL TRACT PHYSIOLOGICAL ACTIVITY (VARIANTS), METHOD FOR PRODUCTION THEREOF AND METHOD FOR CULTURING OF BACTERIUM STRAIN Escherichia coli
KR101370942B1 (en) Novel Bacillus subtilis
KR20010031131A (en) Competitive exclusion culture for swine
CN113040390B (en) Probiotic salt-tolerant lactobacillus johnsonii and application thereof in preventing and treating pathogenic bacteria in livestock and poultry aquiculture
KR100949903B1 (en) Microorganisms preparations for the additional feedstuff and preparation thereof
KR101818859B1 (en) Pseudomonas azotoformans strain KACC 92125P and composition for comprising the same
KR101068531B1 (en) Novel bacteriocin-producing lactic acid bacteria and mixed microbial composition using it for livestocks
KR100371503B1 (en) Probiotic preparations for aquacultured fish and its production method
KR102424594B1 (en) Lactobacillus fermentum OKBL-L.FE 1 strain having anti-inflammatory activity and antimicrobial activity against pathogenic microorganism and uses thereof
KR20090105171A (en) Novel bacteriocin-producing lactic acid bacteria and mixed microbial composition using it
KR101494230B1 (en) Novel strain of Bacillus amyloliquefaciens and animal feed additive containing it
KR20180131948A (en) Pseudomonas extremorientalis strain KACC 81047BP and composition for comprising the same
KR100430298B1 (en) Microorganism preparation complex for using feed additives or treating animal sewage
KR101665334B1 (en) Rhodobacter sphaeroides CB 8521 strain, having the effect of reducing malodor and immune activity in livestock industry, and microbial agent using it
KR101073791B1 (en) Lactobacillus pentosus PL-11 having the dietary enzyme activities, the resistance of bile acid and acid, and the probiotics for fishes using thereof
CN113604387B (en) Salt-tolerant and high-temperature-resistant lactobacillus reuteri and application thereof in prevention and treatment of pathogenic bacteria in livestock and poultry aquaculture
KR101649476B1 (en) Growth inhibitor against bacillus amyloliquefaciens KNU-1 (KCTC18343P) or culture medium thereof
KR101670955B1 (en) Feed for farming-fish and Farming-fish farmed using that
KR100416192B1 (en) A New Strain of Bacillus megaterium PS352 Isolated from Soy Sediment and A Probiotic Usage of the Strain
KR20140091988A (en) Bacillus sp. KR-OF1 as a novel strain with antibacterial activity and use thereof
KR102074672B1 (en) Novel lactobacillus sakei and uses thereof
KR100513167B1 (en) Acid tolerant probiotic Enterococcus faecalis Probio-053 that can suppresses the growth of pathogenic microorganisms and Salmonella gallinarum
KR100553377B1 (en) Probiotic for Inhibiting of Diarrhea and Bloody Excrement of Livestock
KR100206454B1 (en) A novel lactobacillus sp ds-12 and use as a probiotic for fish
KR101658655B1 (en) Novel STRAIN of Lactobacillus plantarum Isolated from Anguilla japonica and Probiotics for Fish Using Thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121227

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20131111

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20141201

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20151224

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20161219

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20180226

Year of fee payment: 16

FPAY Annual fee payment

Payment date: 20190115

Year of fee payment: 17

FPAY Annual fee payment

Payment date: 20200115

Year of fee payment: 18